Advances and challenges in the treatment of myasthenia gravis
Advances and challenges in the treatment of myasthenia gravis
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Myasthenia gravis (MG) is a chronic autoimmune disease with fluctuating muscle weakness and fatigability. Standard immunomodulatory treatment may fail to achieve sufficient improvement with minimal symptom expression or remission of myasthenic symptoms, despite adequate dosing and duration of treatment. Treatment-resistant MG poses a challenge for...
Alternative Titles
Full title
Advances and challenges in the treatment of myasthenia gravis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dab1f26fb3ce40caa40922798b2eb81a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dab1f26fb3ce40caa40922798b2eb81a
Other Identifiers
ISSN
1756-2864,1756-2856
E-ISSN
1756-2864
DOI
10.1177/17562864211065406
